化的向:在糖尿病心肌病中,一种新的治疗方案
1Department of Endocrinology, The Affiliated Hospital of Chifeng University, Chifeng 024005,China.
Cellular signalling
|August 8, 2025
概括
糖尿病心肌病 (DCM) 涉及由于糖尿病 (DM) 的心脏功能障碍. 细胞死亡过程 - - 铁亡 - - 对DCM有显著的贡献,提供了一个新的治疗点.
科学领域:
- 心血管研究研究心血管研究
- 代谢疾病 代谢疾病
- 细胞死亡机制 细胞死亡机制
背景情况:
- 糖尿病心肌病 (DCM) 是糖尿病 (DM) 的主要并发症,导致心肌功能障碍和重塑.
- 对DCM的潜在分子机制的了解仍然很少,因此需要新的治疗方法.
- 铁,一种依赖于铁的调节细胞死亡,涉及脂质过氧化,已成为DCM病变发生的关键参与者.
研究的目的:
- 在糖尿病心肌病的背景下审查铁灭的分子机制.
- 探索铁灭调节在DCM进展中的作用.
- 突出新兴的铁灭抑制剂作为DCM的潜在治疗策略.
主要方法:
- 关于铁亡和糖尿病心肌病的研究的文献综述.
- 在DCM中分析涉及铁和铁恒温的分子途径.
- 在DCM模型中评估针对ferroptosis的药理学药剂的心脏保护作用.
主要成果:
- 铁致死症在糖尿病心肌病的发展和进展中具有关键作用.
- 不调节的铁稳态和脂质过氧化是DCM中铁的关键特征.
- 在DCM模型中,几种抑制铁亡的药物已经显示出显著的心脏保护作用.
结论:
- 铁亡是导致糖尿病心肌病的关键机制.
- 向铁亡途径为DCM提供了一个有前途的新疗法策略.
- 药理上抑制铁亡有潜力预防和治疗DCM.
相关概念视频
Cardiomyopathy IV: Restrictive Cardiomyopathy
31
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
31
Cardiomyopathy III: Hypertrophic Cardiomyopathy
48
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Cardiomyopathy VI: Nursing Management
40
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
40
Heart Failure Drugs: Inotropic Agents
722
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
722


